Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Quell Therapeutics

Quell Therapeutics

Series B
London, UKNov 2021
Healthtech

Quell Therapeutics raised €138M in a Series B round in Nov 2021. The company is based in London, UK. Investors in the round: British Patient Capital, Fidelity Management & Research Company LLC, Janus Henderson Investors and 7 others. Data as of 4 Nov 2026.

← Quell Therapeutics
Amount raised
€138M
€138,346,932
Native amount
156,000,000 USD
Stage
Series B
series b
Investors
10

Provenance & confidence

High confidence
Amount
156,000,000 USD
ECB-at-date → €138M · rate 1.1276 on 2021-11-29
High confidence
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

10 named
British Patient CapitalFidelity Management & Research Company LLCJanus Henderson InvestorsJeito CapitalMonashee Investment Management LLCPoint72 VenturesRidgeback Capital InvestmentsSV Health InvestorsSyncona PartnersTekla Capital Management
Date
Nov 2021
Round type
series b
Amount (EUR)
€138M

Other rounds

same company

This is the company's only recorded round.

Related news